EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 19 January 2023

News

Borders should no longer be barriers: The EU-X-CT Multi-stakeholder Initiative
18 January 2023

EFGCP and EFPIA launch initiative to enable cross-border access to clinical trials for all patients in Europe Read more

The Power of Innovation

Almost all cases of cervical cancer are caused by an infection from human papillomavirus (HPV). Since 2006, several vaccines against HPV have become available in the EU27, providing the opportunity to prevent more than 27,000 cervical cancer cases and 12,000 deaths, each year. Find out more.

Events

enter the EURORDIS PHOTO AWARD 2023
22 January 2023 (Photo Award)

Celebrating inspiring individuals, organisations and companies who make a real difference in the rare disease community... Read more

Launch event of the RETHINKING Alzheimer's disease White Paper
24 January 2023 (Virtual event)

Registrations are now open. Read more

RETHINKING THE FUTURE OF CANCER CARE
25 January 2023 (Virtual event)

Organised in partnership with the FT Live Read more

Even spaceships need a launchpad
31 January 2023 (Virtual event)

Bring the regulatory framework for innovative medicines into the future Read more

What we are reading

Bayer shifts pharma focus away from ‘innovation unfriendly’ Europe
On 16 January 2023 (Financial Times)

Bayer has said it is shifting the focus of its pharmaceutical business to the US and away from Europe and the UK, where... Read more

Solving the issue of medicine shortages in the EU
On 18 January 2023 (Euractiv)

The European Commission is pointing to the sharp increase in demand along with insufficient production capacity as the... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu